LOPD in Undiagnosed Patients Estimated at 1% in US and Canada

LOPD in Undiagnosed Patients Estimated at 1% in US and Canada

311527

LOPD in Undiagnosed Patients Estimated at 1% in US and Canada

The prevalence of late-onset Pompe disease (LOPD) in people across the U.S. and in Montreal, Canada, who lack an official diagnosis but have its characteristic neuromuscular symptoms — including neck and proximal muscle weakness or elevated creatine kinase levels (a marker of muscle damage) — is estimated to be 1%. The study reporting the finding, “Investigating Late-Onset Pompe Prevalence in Neuromuscular Medicine Academic Practices,” was published in Neurology Genetics. Previous studies have estimated the prevalence of…

You must be logged in to read/download the full post.